State Street’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.1M | Buy |
|
|||||
|
2025
Q2 | $38.3M | Buy |
|
|||||
|
2025
Q1 | $25.6M | Sell |
|
|||||
|
2024
Q4 | $29M | Buy |
|
|||||
|
2024
Q3 | $29.7M | Buy |
|
|||||
|
2024
Q2 | $15.8M | Buy |
|
|||||
|
2024
Q1 | $16.4M | Buy |
|
|||||
|
2023
Q4 | $3.16M | Buy |
|
|||||
|
2023
Q3 | $2.03M | Buy |
|
|||||
|
2023
Q2 | $2.94M | Buy |
|
|||||
|
2023
Q1 | $841K | Buy |
|
|||||
|
2022
Q4 | $733K | Buy |
|
|||||
|
2022
Q3 | $357K | Hold |
|
|||||
|
2022
Q2 | $287K | Sell |
|
|||||
|
2022
Q1 | $1.21M | Buy |
|
|||||
|
2021
Q4 | $2.16M | Buy |
|
|||||
|
2021
Q3 | $3.04M | Buy |
|
|||||
|
2021
Q2 | $6.93M | Buy |
|
|||||
|
2021
Q1 | $8.38M | Buy |
|